Optimizing cholesterol treatment in patients with muscle complaints

Rosenson, Robert S., Baker, Steven, Banach, Maciej, Borow, Kenneth M., Braun, Lynne T., Bruckert, Eric, Brunham, Liam R., Catapano, Alberico L. +11 more·2017·Journal of the American College of Cardiology
DOI 10.1016/j.jacc.2017.07.752

Cited by (193)

Items 101–193 of 193

  1. Statin administration activates system xC − in skeletal muscle: a potential mechanism explaining statin-induced muscle pain
    Irena A. Rebalka, Andrew W. Cao, Linda L. May, Mark Andrew Tarnopolsky, Thomas James Hawke · 2019 · American Journal of Physiology-Cell Physiology
  2. Evolocumab treatment in patients with HIV and hypercholesterolemia/mixed dyslipidemia: BEIJERINCK study design and baseline characteristics
    Franck Boccara, Princy N. Kumar, Bruno Caramelli, Alexandra Calmy, J. Antonio G. López, Sarah L Bray, Marcoli Cyrille, Robert S. Rosenson · 2019 · American Heart Journal
  3. Lipid-lowering Therapies in Myositis
    Marisa C. Mizus, Eleni Tiniakou · 2020 · Current Rheumatology Reports
  4. Biological Actions, Implications, and Cautions of Statins Therapy in COVID-19
    Chengyu Liu, Wanyao Yan, Jiajian Shi, Shun Wang, Anlin Peng, Yuchen Chen, Kun Huang · 2022 · Frontiers in Nutrition
  5. Recurrent Atherosclerotic Cardiovascular Disease Events Potentially Prevented with Guideline-Recommended Cholesterol-Lowering Therapy following Myocardial Infarction
    Swati Sakhuja, Vera Bittner, Todd M. Brown, Michael E. Farkouh, Emily B. Levitan, Monika M. Safford, Mark Woodward, Ligong Chen, Ruoyan Sun, Nafeesa N Dhalwani et al. · 2023 · Cardiovascular Drugs and Therapy
  6. Unmet Patient Need in Statin Intolerance: the Clinical Characteristics and Management
    Harrison, Teresa N., Hsu, Jin-Wen Y., Rosenson, Robert S., Levitan, Emily B., Muntner, Paul, Cheetham, T. Craig, Wei, Rong, Scott, Ronald D., Reynolds, Kristi · 2018 · Cardiovascular Drugs and Therapy
  7. Current Perspectives on the Attainment of Lipid Modification Goals Relating to the Use of Statins and Ezetimibe for the Prevention of Cardiovascular Disease in the United Kingdom
    Tim Reynolds, Alison Pottle, Sadat Haider Quoraishi · 2021 · Vascular Health and Risk Management
  8. Medical Expenditures Among Medicare Beneficiaries with Statin-Associated Adverse Effects Following Myocardial Infarction
    Lisandro Damián Colantonio, Luqin Deng, Ligong Chen, Michael E. Farkouh, Keri L. Monda, David J. Harrison, Juan Francisco Maya, Meredith L. Kilgore, Paul Muntner, Robert S. Rosenson · 2018 · Cardiovascular Drugs and Therapy
  9. Enhancing the Operational Semantics of the Entity-Relationship Model.
    Christine E. Parent, Stefano Spaccapietra · 1985 · Discovery Science
  10. ST segment elevation myocardial infarction (STEMI) patients are more likely to achieve lipid-lowering treatment goals
    Ünal Güntekin, Veysel Tosun, Ali Yaşar Kılınç, Gündüzalp Saydam, Necmettin Korucuk, Mehmet Nuri Bozdemır · 2018 · Medicine
  11. The Burden of Statin Therapy based on ACC/AHA and NCEP ATP-III Guidelines: An Iranian Survey of Non-Communicable Diseases Risk Factors
    Samaneh Asgari, Hengameh Abdi, Alireza Mahdavi Hezaveh, Alireza Moghisi, Koorosh Etemad, Hassan Riahi Beni, Davood Khalili · 2018 · Scientific Reports
  12. Improving the global care of familial hypercholesterolaemia: Starting the ball rolling
    Kausik Kumar Ray, Gerald Francis Watts · 2018 · Atherosclerosis
  13. Synopsis of an integrated guidance for enhancing the care of familial hypercholesterolaemia: an Australian perspective
    Gerald Francis Watts, DAVID R. SULLIVAN, David L. Hare, Karam Kostner, Ari Horton, Damon A. Bell, Tom Brett, Ronald J. Trent, Nicola Kazia Poplawski, Andrew C. Martin et al. · 2021 · American Journal of Preventive Cardiology
  14. Dynamic urine proteome changes in a rat model of simvastatin-induced skeletal muscle injury
    Jing Wei, Yuhang Huan, Ziqi Heng, Chenyang Zhao, Lulu Jia, Yuncui Yu, Youhe Gao · 2022 · Journal of Proteomics
  15. Efficacy and Safety of Bempedoic Acid to Prevent Cardiovascular Events in Individuals at Risk of Cardiovascular Diseases: A Meta-Analysis of Randomized-Control Trials
    Gautham Varun Krishna Mohan, Venkata Sai Harshabhargav Chenna, Gayathri Tirumandyam, Abdur Rehman Mian, Atif Rashid, Faraz Saleem · 2023 · Cureus
  16. Lipid-Lowering Therapy for Primary Cardiovascular Prevention in Older Adults. Consensus Statement of the Russian Association of Gerontologists and Geriatricians, National Society on Atherosclerosis, Russian Society of Cardiology, Association of Clinical Pharmacologists
    Yu. V. Kotovskaya, О. Н. Ткачева, И. В. Сергиенко · 2020 · Kardiologiia
  17. Exercise Training Improves Muscle Performance and Quality of Life in Patients With Statin Muscle Symptoms
    Robert S. Rosenson, Beth A. Taylor, Irwin J. Kurland · 2021 · Journal of the American College of Cardiology
  18. The Role of Red Yeast Rice Based Preparations for Non-Pharmacological Correction of Dyslipidemia in Patients with Low and Moderate Cardiovascular Risk (Expert Opinion)
    Ежов Марат Владиславович, Alberico Luigi Catapano, Carlos Escobar, Valery V. Kukharchuk, Mikhail Ivanovich Voevoda, Oxana M. Drapkina, Svetlana Anatolievna Shalnova, Antonina Vladimirovna Starodubova, Victor S. Gurevich, Шапошник Игорь Иосифович et al. · 2020 · Rational Pharmacotherapy in Cardiology
  19. COQ2 polymorphisms are not associated with increased risk of statin-induced myalgia/myopathy in the Czech population
    Jaroslav Alois Hubacek, Věra Adámková, Lukáš Zlatohlávek, Lenka Steiner Mrazova, Michal Vrablı́k · 2017 · Drug Metabolism and Personalized Therapy
  20. Practical guide for the use of PCSK9 inhibitors in Portugal
    Ricardo Fontes‐Carvalho, Pedro Marques Silva, Elisabete Rodrigues, Francisco Pestana Araujo, Cristina Gavina, Jorge Ferreira, João Morais · 2019 · Revista Portuguesa de Cardiologia (English Edition)
  21. Trial designs for statin muscle intolerance
    Robert S. Rosenson · 2017 · Current Opinion in Lipidology
  22. Diagnostik und Therapie von statinassoziierten Muskelsymptomen
    Ursula Kassner, Stefanie Anke Grunwald, Dominik Spira, Nikolaus Buchmann, Thomas Bobbert, Elisabetta Gazzerro, Tim Hollstein, Simone Spuler, Elisabeth Steinhagen‐Thiessen · 2021 · Der Internist
  23. Metformin's impact on statin‐associated muscle symptoms: An analysis of ACCORD study data and research materials from the NHLBI Biologic Specimen and Data Repository Information Coordinating Center
    Nicholas W. Carris, Athanasios Tsalatsanis, Srinivas M. Tipparaju, Feng Cheng, Ronald R. Magness, Ambuj Kumar · 2018 · Diabetes Obesity and Metabolism
  24. Optimizing Cholesterol Management Improves the Benefits of Percutaneous Coronary Intervention
    Robert S. Rosenson, Lisandro Damián Colantonio, Sascha N. Goonewardena · 2020 · Journal of the American College of Cardiology
  25. False versus True Statin Intolerance in Patients with Peripheral Artery Disease
    Jörn Fredrik Dopheide, Patrick Gillmann, David Spirk, Meisam Khorrami Borozadi, Luise Adam, Heinz Drexel · 2022 · Journal of Clinical Medicine
  26. Statin Intolerance: An Overview for Clinicians
    Stanisław Surma, Joanna Lewek, Peter Edward Penson, Maciej Banach · 2023 · Contemporary diabetes
  27. The year in cardiology 2017: prevention
    Børge Grønne Nordestgaard, Francesco Cosentino, Ulf Landmesser, Ulrich Laufs · 2017 · European Heart Journal
  28. Clinical guidance on the contemporary use of proprotein convertase subtilisin/kexin type 9 monoclonal antibodies
    Natalie C. Ward, Michael M. Page, Gerald Francis Watts · 2019 · Diabetes Obesity and Metabolism
  29. Effect of Mesembryanthemum crystallinum and its derived D‐pinitol on HMG‐CoA reductase and tyloxapol‐induced hyperlipedemia
    Jun‐Hui Choi, Se‐Eun Park, Seung Kim · 2024 · eFood
  30. Management of hypercholesterolemia, appropriateness of therapeutic approaches and new drugs in patients with high cardiovascular risk
    Roberto Vettor, Roberto Serra · 2018 · Italian Journal of Medicine
  31. PRavastatin Versus FlUVastatin After Statin Intolerance: The PRUV-Intolerance Study With Propensity Score Matching
    Ji Woong Roh, Kyeong‐Hyeon Chun, Moonjong Kang, Chan Joo Lee, Jaewon Oh, Chi Young Shim, Chul‐Min Ahn, Jung‐Sun Kim, Byeong‐Keuk Kim, Sungha Park et al. · 2019 · The American Journal of Medicine
  32. Vitamin D and SAMS
    Marcin A. Bartłomiejczyk, Peter Edward Penson, Maciej Banach · 2020 · Contemporary cardiology
  33. Personalized rosuvastatin therapy in problem patients with partial statin intolerance
    Aleksandr B. Shek, Ravshanbek D. Kurbanov, Rano B. Alieva, Guzal J. Abdullaeva, Aleksandr V. Nagay, Alisher A. Abdullaev, Shavkat U. Hoshimov, Ulugbek I. Nizamov · 2018 · Archives of Medical Science - Atherosclerotic Diseases
  34. Efficacy and safety of xuezhikang once per day versus two times per day in patients with mild to moderate hypercholesterolaemia (APEX study): a protocol for a multicentre, prospective randomised controlled, open-label, non-inferiority study
    Zexuan Wu, Dexi Wu, Jingzhou Jiang, Ailan Chen, Dong-Dan Zheng, Jianhao Li, Yugang Dong, Yili Chen · 2020 · BMJ Open
  35. Combination of atorvastatin and gemfibrozil plus physical activity: an animal model of statin/fibrate-induced myopathy
    Mohsen Zabihi, Fatemeh Askarian, Seyedhossein Hekmatimoghaddam, Mohammad Sajjad Zabihi, Firouzeh Vahidi · 2020 · Somatosensory & Motor Research
  36. Ascorbic Acid Significantly Decreases Creatine Kinase Plasma Levels in an Animal Model of Statin/Fibrate-Induced Myopathy
    Mohsen Zabihi, Fatemeh Askarian, Seyedhossein Hekmatimoghaddam, Mohammadreza Rashidi Nooshabadi, Mohammad Sajjad Zabihi, Seyed Ruhollah Mousavinasab · 2021 · Advances in Pharmacological and Pharmaceutical Sciences
  37. Incidence of statin-associated muscle symptoms in patients taking statins with RYR1 or CACNA1S variants
    Natasha Petry, Amanda Massmann, Megan E. Bell, April Schultz, Joel Van Heukelom · 2024 · Personalized Medicine
  38. Effects of evolving lipid-lowering drugs on carbohydrate metabolism
    Vasilis Tsimihodimos, Moses Elisaf · 2017 · Diabetes Research and Clinical Practice
  39. Statinassoziierte Muskelsymptome und Statinmyopathie
    Ilka Schneider, Stephan Zierz · 2019 · Neurologie up2date
  40. Coronary artery calcium scoring in patients with statin associated muscle symptoms: Prescribing statins for those most likely to benefit
    Carl E. Orringer, Michael Joseph Blaha, Neil J. Stone · 2021 · Journal of clinical lipidology
  41. Safety Considerations of Pharmacological Treatment
    Kyuho Kim, Sung Hee Choi · 2021 · Stroke revisited
  42. Gaps in Dyslipidemia Care Among Working‐Aged Individuals With Employer‐Sponsored Health Care
    Dov Shiffman, Judy Z. Louie, James J. Devlin, Joshua W. Knowles, Michael John McPhaul · 2020 · Journal of the American Heart Association
  43. Protective effect of garlic juice on renal function and lipid profile in rats fed with high-fat diet
    Hadeel Ahmed Alsufyani, Basma M. H. Zawawi · 2021 · Saudi Journal for Health Sciences
  44. Topical issues concerning modern lipid-lowering therapy
    Andrey V. Susekov · 2022 · Consilium Medicum
  45. Bempedoic Acid a Small Molecule Drug Process and Synthesis, Innovation And /Or Advantages, Development Status And /Or Regulatory Status
    Krishnasarma Pathy · 2019 · Surgery & Case Studies Open Access Journal
  46. Low-density lipoprotein cholesterol levels among individuals experiencing statin-associated symptoms: Data from the REasons for Geographic And Racial Differences in Stroke (REGARDS) study
    Rikki M. Tanner, Lisandro Damián Colantonio, Meredith L. Kilgore, Matthew T. Mefford, Dayl T. Chachappan, Katherine E. Mues, Monika M. Safford, Robert S. Rosenson, Paul Muntner · 2020 · Journal of clinical lipidology
  47. Tratamiento hipolipemiante en la era COVID-19
    Manuel Frías Vargas, Ángel Díaz Rodríguez, B. Díaz Fernández · 2020 · Medicina de Familia SEMERGEN
  48. The Importance of Exercise in Cardiometabolic Health in Patients Reporting Statin-Associated Muscle Symptoms
    Robert S. Rosenson · 2023 · Journal of the American College of Cardiology
  49. Management of Statin Intolerance
    Marcin A. Bartłomiejczyk, Peter Edward Penson, Maciej Banach · 2020 · Contemporary cardiology
  50. Association of Coenzyme Q10 Supplementation With Statin-Associated Muscle Symptoms in Long-Term Statin Users
    Muhammad Zeeshan, Ahmad Raza, Aleena Waseem, Sadia Sadia, Muhammad Rehan Mushtaq, Shajee Siddiqui, Hasnat Shabbir, PC Sarker · 2025 · Cureus
  51. High-Intensity Statin versus Upfront Equivalent-Dose Combination of Moderate-Intensity Statin with Ezetimibe Following Acute Myocardial Infarction (ROSUZET-AMI): protocol of a multicentre, open-label, randomised non-inferiority trial
    Eun Ho Choo, Chan Joon Kim, Byung‐Hee Hwang, Kwan Yong Lee, Gyu Chul Oh, Sungmin Lim, Ik Jun Choi, Dong‐Bin Kim, O Sung Kwon, Sunam Lee et al. · 2025 · BMJ Open
  52. Statin-Associated Immune-Mediated Necrotizing Myopathy: An Underrecognised Cause of Progressive Muscle Weakness in Primary Care
    Jee Tat Ong, Teh Rohaila Jamil, Say Yee Loo · 2026 · Cureus
  53. Guia prático para a utilização dos inibidores da PCSK9 em Portugal
    Ricardo Fontes‐Carvalho, Pedro Marques Silva, Elisabete Rodrigues, Francisco Pestana Araujo, Cristina Gavina, Jorge Ferreira, João Morais · 2019 · Revista Portuguesa de Cardiologia
  54. Definitions of Statin-Associated Muscle Symptoms
    Robert S. Rosenson · 2020 · Contemporary cardiology
  55. Study on the Effect of Xuezhikang Combined with Rosuvastatin on Lipid Regulation in Patients with Atherosclerotic Cardiovascular Disease
    丽艳 张 · 2020 · Advances in Clinical Medicine
  56. Meta-Analysis of Lowering LDL Cholesterol and its Impact on the Cardiovascular System
    Бадалян Самсон Сергеевич, Syune V. Markosyan, Hajra Tariq, Zeeshan S. Malik, Andleeb Asghar · 2023 · Pakistan Journal of Medical and Health Sciences
  57. Differential Diagnosis of Statin-Associated Muscle Symptoms
    Marshall B. Elam, Richard Dale Childress · 2020 · Contemporary cardiology
  58. Individualizing Treatment with Statin Therapy.
    Harold Edward Bays, Michael E. Cobble · 2018 · PubMed
  59. CETP inhibition in the REVEAL trial: could we aim higher?
    Amirhossein Sahebkar, Dimitri P. Mikhailidis, Maciej Banach · 2020 · Archives of Medical Science
  60. Defining the role of bempedoic acid in lowering low-density lipoprotein cholesterol
    Oleksii Korzh · 2020 · Journal of Applied Pharmaceutical Science
  61. Effect of Dyslipidemia Therapy on Creatinine Kinase Activity Level in Patients with Heart Disease
    Wa Ode Dila Sulistian, Muhamad Robiul Fuadi, Soebagijo Poegoeh Edijanto, Mochamad Yusuf Alsagaff · 2021 · INDONESIAN JOURNAL OF CLINICAL PATHOLOGY AND MEDICAL LABORATORY
  62. Ascorbic Acid Greatly Decreases Creatine Kinase Levels in An Animal Model of Statin/Fibrate-Induced Myopathy
    Fatemeh Askarian, Mohsen Zabihi, Seyedhossein Hekmatimoghaddam, Mohammadreza Rashidi Nooshabadi, Mohammad Sajjad Zabihi · 2021 · Research Square
  63. Secondary Prevention of Atherosclerotic Cardiovascular Disease
    David Power, Robert S. Rosenson · 2022 · Interventional Cardiology
  64. Predictors of statin adherence among statin users in primary care using real-world data
    Shagoofa Rakhshanda, Kerry‐Anne Rye, Siaw‐Teng Liaw, Joel Rhee, Jitendra Jonnagaddala · 2026 · medRxiv
  65. Index indicates cholesterol management strategy for statin related muscle pain
    Susan Mayor · 2017 · BMJ
  66. The shape of things to come in lipid management: a feast of reason
    Gerald Francis Watts, Erik S.G. Stroes · 2017 · Current Opinion in Lipidology
  67. The year in cardiology 2017: prevention
    Børge Grønne Nordestgaard, Francesco Cosentino, Ulf Landmesser, Ulrich Laufs · 2018 · Cardiologia Croatica
  68. Genetic disorders of lipoprotein metabolism
    Deepak Bhatnagar, Jonathan D. Schofield, Handrean Soran · 2019 · Elsevier eBooks
  69. Bempedoic acid: A new player in lipid-lowering therapies
    Ada M. Cuevas, Rodrigo Alonso K · 2020 · Journal of clinical lipidology
  70. Pharmacological prevention of ischemic stroke and tia : epidemiological aspects and how to improve treatment
    Lukas Geary · 2020 · Figshare
  71. Response to “Effect of monacolin K and COQ10 supplementation in hypertensive and hypercholesterolemic subjects with metabolic syndrome”
    Marilyn K. Schoenle, Stephanie L. Ballard · 2018 · Biomedicine & Pharmacotherapy
  72. Diagnosis and Management of Coronary Artery Disease in Athletes
    Prashant Rao, David Shipon · 2021 · Springer eBooks
  73. Bempedoic Acid: A First-in-Class Agent for Lowering Cholesterol Levels
    Candis M. McGraw-Senat, Nakoasha Dillard, Taylor Guelda, Essie Samuel, Hua Ling · 2021 · The Senior Care Pharmacist
  74. Intolerancia y miopatía por estatinas
    Raúl Ariza Andraca, José Halabe Cherem, Alberto Lifshitz Guinzberg · 2020 · Acta Médica Grupo Ángeles
  75. Statin intolerance – Prevalence and practical management in a specialized lipid clinic
    Yannick Turdo, Tinh‐Hai Collet · 2022 · medRxiv
  76. Conclusions and Future Directions
    Beth A. Taylor, Paul D. Thompson · 2020 · Contemporary cardiology
  77. Loạt ca bệnh tiêu cơ vân cấp khi điều trị bằng statin có liên quan đến đa hình gen SLCO1B1
    Trần Đình Tuyên, Ngọc Quang Nguyễn, Thị Lan Anh Lương · 2023 · Tạp chí Tim Mạch Học Việt Nam
  78. Anti-cholesterol Effects and Molecular Mechanism Study of Mixture of Atractylodes Macrocephala and Amomum Villosum Extracts
    Ha Rim Kim, Ye Seul Kim, Kang Beom Kwon, Hyun-Jong Jung · 2022 · 동의생리병리학회지
  79. Clinical Follow-Up of Patients after Coronary Artery Bypass Grafting
    José Carlos Oliveira · 2024 · Cardiology and cardiovascular medicine.
  80. Management of a patient at very high cardiovascular risk with myositis during high-intensity statin therapy
    Daria Yu. Sedykh, В. В. Кашталап, О. Л. Барбараш · 2024 · Meditsinskiy sovet = Medical Council
  81. Challenges in the management of familial hypercholesterolemia: a case report
    Joanna K. Rogozik, Marcin Grabowski, Renata Główczyńska · 2024 · Frontiers in Cardiovascular Medicine
  82. Statins in the practice of an internal medicine specialist: A review
    Andrey V. Susekov · 2024 · Consilium Medicum
  83. CORRECTION OF DYSLIPIDEMIA: HISTORICAL ASPECT AND MODERN PERSPECTIVE ON THE PROBLEM (REVIEW, PART I)
    Dmytro D. Diachuk, Galina Z. Moroz, Oleksandr M. Tkalenko · 2025 · Clinical and Preventive Medicine
  84. Urine Proteome Changes in a Simvastatin-Induced Skeletal Muscle Injury Rat Model
    Jing Wei, Yuhang Huan, Ziqi Heng, Chenyang Zhao · 2025 · Springer eBooks
  85. Electronic health record (EHR)-detectable phenotypes of statin intolerance: Prevalence and validation in real-world general practice
    Shagoofa Rakhshanda, Joel Rhee, Siaw‐Teng Liaw, Kerry‐Anne Rye, Jitendra Jonnagaddala · 2025 · medRxiv
  86. Implication of the Androgen Receptor in Muscle–Liver Crosstalk: An Overlooked Mechanistic Link in Lean-MASLD
    Eleni-Myrto Trifylli, Charalambos Haris Charalambous, Nikolaos Spiliotopoulos, Nikolaos Papadopoulos, Anastasia Oikonomou, Spilios Manolakopoulos, Melanie J. Deutsch · 2025 · Livers
  87. Interventions to manage intolerance among patients prescribed statins for primary prevention of cardiovascular diseases: A systematic review and meta-analysis
    Shagoofa Rakhshanda, Joel Rhee, Siaw‐Teng Liaw, Kerry‐Anne Rye, Jitendra Jonnagaddala · 2026 · medRxiv
  88. Đánh giá ảnh hưởng trên cơ vân ở bệnh nhân hội chứng mạch vành cấp được điều trị bằng statin
    Trần Đình Tuyên, Nguyễn Đặng Duy Quang, Lương Thị Lan Anh, Lê Thị Mến · 2021 · Tạp chí Tim Mạch Học Việt Nam
  89. Management of lipid disorders in diabetes: an overview of current recommendations
    Przemysław Witek, Edyta Cichocka, Janusz Gumprecht · 2026 · Current Topics in Diabetes
  90. Severe Hyperlipidemia and Multifocal Atherosclerosis With Negative Genetic Testing for Familial Hypercholesterolemia: A Case Report
    Dawid Buczyński, Anna Róg, Mateusz Pałka, Michał Susuł, Renata Rajtar-Salwa · 2026 · Cureus
  91. Österreichischer Lipidkonsensus 2026
    Florian Kronenberg, Florian Höllerl, Helmut Brath, Gersina Rega‐Kaun, Susanne Greber‐Platzer, Christoph Weiser, Dominic P Klein, Nikolaus Riesenhuber, Christoph J. Binder, Johanna Maria Brix et al. · 2026 · Wiener klinische Wochenschrift
  92. Liver enzyme elevations during statin–ezetimibe therapy in ABCG2 c.421C>A variant carriers: a case series and narrative review
    Livija Šimičević, Lana Ganoci, Ena Karačić, Tamara Božina, Ivan Pećin, Vladimir Trkulja, Nada Božina · 2026 · Frontiers in Pharmacology
  93. Dietary patterns, nutrition, and food–drug interactions during statin therapy: a narrative review
    M.J. Mazur, Rafal Lenard, Seda Önal, Joanna Popiołek-Kalisz · 2026 · Global Perspectives on Nutrition